IMI (Innovative Medicines Initiative) has launched IMI2 - Call 10, with topics on diabetes & hypoglycaemia, big data & prostate cancer, pain, paediatric clinical trials, biomanufacturing, genes & disease, the patient perspective, and autism.

Call description

Call ID:  H2020-JTI-IMI2-2016-10-two-stage
Action Type:   RIA – Research and Innovation Actions


  • Topic 1: Understanding hypoglycaemia: the underlying mechanisms and addressing clinical determinants as well as consequences for people with diabetes by combining databases from clinical trials
  • Topic 2: How big data could support better diagnosis and treatment outcomes for prostate cancer (part of the Big Data for Better Outcomes programme)
  • Topic 3: Improving the care of patients suffering from acute or chronic pain (this topic includes three subtopics on patient reported outcomes; biomarkers; and chronic pelvic pain)
  • Topic 4: Creation of a pan-European paediatric clinical trials network
  • Topic 5: Biomanufacturing 2020: development of innovative high throughput analytical tools and methods to characterize cell culture fluid during development and commercial cell culture processes
  • Topic 6: Unlocking the solute carrier gene-family for effective new therapies (unlock SLCs)
  • Topic 7: Patient perspectives in medicines lifecycle
  • Topic 8: Personalised medicine approaches in autism spectrum disorders

Please read the IMI2 Call 10 Topics Text  for full details of these topics, incuding the budget breakdown and the General Conditions for the Call for proposals

Please note that entering and submitting short proposals for this Call can only be done through the electronic submission system of the Horizon 2020 Participant Portal. The submission system will open for proposals under this Call on 4 January 2017

Indicative budget

  • From EFPIA companies and IMI2 Associated Partners: EUR 174 140 000
  • From the IMI2 JU: EUR 173 890 000

Key dates

  • Publication date: 21 December 2016
  • Stage 1 submission start date: 4 January 2017
  • Stage 1 submission deadline: 28 March 2017 – 17:00:00 Brussels time


More information: